TY - JOUR
T1 - Biodegradable polymer composites with osteogenic potential
AU - Lebedev Sergey, M.
AU - Chistokhin Dmitry, M.
AU - Shchadenko Sergey, V.
AU - Dzuman Anna, N.
AU - Nikolaeva Olga, O.
AU - Mitrichenko Dmitry, V.
AU - Prosolov Alexander, B.
AU - Khlusov Igor, A.
N1 - Funding Information:
Source of financing. The study was partially supported by the Council for Grants of the President of the Russian
Funding Information:
Federation for State Support of Leading Scientific Schools of the Russian Federation (Grant No. SS-2495.2020.7).
Publisher Copyright:
© 2020 Siberian State Medical University. All rights reserved.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021
Y1 - 2021
N2 - The aim was to study the basic physico-mechanical properties of hydroxyapatite (HA) composites (up to 25-50 wt%) with polylactide (PLA-HA) and poly(e-caprolactone) (PCL-HA) prepared by melt compounding, as well as the osteogenic potential of PLA-HA in vivo. Materials and methods. All biodegradable polymer composites were prepared by hot melt compounding and studied by dielectric spectroscopy in frequency domain, optical microscopy, X-ray diffraction analysis and tensile tests. An ability of PLA-5 wt% HA composites prepared by 3D-printing to induce bone tissue growth in vivo was detected with the help of ectopic subcutaneous test in inbred mice. Results. Values of the real part of complex permittivity of PLA-HA and PCL-HA composites are increased by 15-30% compared to those for initial PLA and PCL, while tand loss factor tanδ does not exceed 0.02 for PLAbased composites and 0.2 for PCL-based composites. The crystallinity degree of PLA-HA composites is increased by 3 and 6 times with an increase of HA content from 25 to 50 wt% respectively compared to the indicator for PLA. The crystallinity degree of PCL-HA composites with 25 wt% HA is increased by 2 times compared to the value for PCL. It is due to the fact that HA powder particles play the role of additional nucleation centers. For all this, mechanical strength of composites diminished statistically. Even lowest HA content (5 wt%) in PLA-HA composites prepared by 3D-printing increased the incidence of ectopic osteogenesis by 40%. Conclusion. Designed biodegradable composites have a practical use potential for bone tissue engineering.
AB - The aim was to study the basic physico-mechanical properties of hydroxyapatite (HA) composites (up to 25-50 wt%) with polylactide (PLA-HA) and poly(e-caprolactone) (PCL-HA) prepared by melt compounding, as well as the osteogenic potential of PLA-HA in vivo. Materials and methods. All biodegradable polymer composites were prepared by hot melt compounding and studied by dielectric spectroscopy in frequency domain, optical microscopy, X-ray diffraction analysis and tensile tests. An ability of PLA-5 wt% HA composites prepared by 3D-printing to induce bone tissue growth in vivo was detected with the help of ectopic subcutaneous test in inbred mice. Results. Values of the real part of complex permittivity of PLA-HA and PCL-HA composites are increased by 15-30% compared to those for initial PLA and PCL, while tand loss factor tanδ does not exceed 0.02 for PLAbased composites and 0.2 for PCL-based composites. The crystallinity degree of PLA-HA composites is increased by 3 and 6 times with an increase of HA content from 25 to 50 wt% respectively compared to the indicator for PLA. The crystallinity degree of PCL-HA composites with 25 wt% HA is increased by 2 times compared to the value for PCL. It is due to the fact that HA powder particles play the role of additional nucleation centers. For all this, mechanical strength of composites diminished statistically. Even lowest HA content (5 wt%) in PLA-HA composites prepared by 3D-printing increased the incidence of ectopic osteogenesis by 40%. Conclusion. Designed biodegradable composites have a practical use potential for bone tissue engineering.
KW - Ectopic osteogenesis
KW - Hydroxyapatite
KW - In vivo
KW - Melt compounding
KW - Physicochemical properties
KW - Poly(e-caprolactone)
KW - Poly(lactic acid)
UR - http://www.scopus.com/inward/record.url?scp=85100487494&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100487494&partnerID=8YFLogxK
U2 - 10.20538/1682-0363-2020-4-119-129
DO - 10.20538/1682-0363-2020-4-119-129
M3 - Article
AN - SCOPUS:85100487494
VL - 19
SP - 119
EP - 129
JO - Bulletin of Siberian Medicine
JF - Bulletin of Siberian Medicine
SN - 1682-0363
IS - 4
ER -